Supplement study for pancreatic cancer patients withdrawn before it began
NCT ID NCT05360745
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if a food supplement called ARACOMPLEX® could help maintain quality of life in patients with advanced pancreatic cancer receiving chemotherapy. The supplement contains maca extract, vitamins, and minerals. However, the trial was withdrawn before enrolling any participants, so no data were collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ARACOMPLEX® (a food supplement with maca extract, vitamins, and minerals)
What this could lead to
If it worked, this could point toward a simple nutritional supplement to help maintain quality of life during chemotherapy for advanced pancreatic cancer.
What could go wrong
The trial was withdrawn before enrolling any participants, so no results are available. Even if conducted, food supplements rarely have strong effects on cancer outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for QUALITY OF LIFE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.